Vertex Pharmaceuticals, Inc. (VRTX)
541.69
-5.86
(-1.07%)
USD |
NASDAQ |
Aug 28, 16:00
541.81
+0.12
(+0.02%)
After-Hours: 20:00
Vertex Pharmaceuticals Cash from Operations (Annual) : 3.631B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 3.631B |
| December 31, 2024 | -492.60M |
| December 31, 2023 | 3.537B |
| December 31, 2022 | 4.130B |
| December 31, 2021 | 2.644B |
| December 31, 2020 | 3.254B |
| December 31, 2019 | 1.569B |
| December 31, 2018 | 1.270B |
| December 31, 2017 | 844.94M |
| December 31, 2016 | 236.10M |
| December 31, 2015 | -365.43M |
| December 31, 2014 | -513.20M |
| December 31, 2013 | -51.57M |
| December 31, 2012 | 267.84M |
| December 31, 2011 | 143.74M |
| December 31, 2010 | -635.44M |
| December 31, 2009 | -427.59M |
| December 31, 2008 | -226.48M |
| Date | Value |
|---|---|
| December 31, 2007 | -252.48M |
| December 31, 2006 | -22.48M |
| December 31, 2005 | -172.07M |
| December 31, 2004 | -142.16M |
| December 31, 2003 | -167.62M |
| December 31, 2002 | -79.54M |
| December 31, 2001 | -8.074M |
| December 31, 2000 | -16.64M |
| December 31, 1999 | -31.81M |
| December 31, 1998 | -31.06M |
| December 31, 1997 | -9.362M |
| December 31, 1996 | -40.25M |
| December 31, 1995 | -15.95M |
| December 31, 1994 | -14.68M |
| December 31, 1993 | 8.632M |
| December 31, 1992 | -5.327M |
| December 31, 1991 | -2.524M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Gilead Sciences, Inc. | 10.02B |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Sionna Therapeutics, Inc. | -66.30M |
| Regeneron Pharmaceuticals, Inc. | 4.979B |
| Biogen, Inc. | 2.205B |